Letter to the Editor
Sir: Isonicotinylhydrazide, also known as isoniazid, is awell-known agent for treatment of mycobacterial infections. Itis also used for prevention of tuberculosis, given 300 mg/dayfor a period of at least 6 months. In vivo studies, usingbenzylamine as substrate, have demonstrated that isoniazid intherapeutic doses inhibits plasma monoamine oxidase (MAO)with no significant effect on platelet MAO.
This PDF is free for all visitors!
Save
Cite